ArticleJournal of thoracic disease2019

A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.

Yunpeng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.